bebtelovimab   Click here for help

GtoPdb Ligand ID: 11921

Synonyms: LY-3853113 | LY-CoV-1404 | LY-CoV1404 | LY3853113
Compound class: Antibody
Comment: Bebtelovimab (LY3853113) is a SARS-CoV-2-neutralising monoclonal antibody that binds to the virus' spike surface glycoprotein [2]. It was reported to be effective against the delta and early omicron variants (B.1.617.2 and B.1.1.529 respectively). As of July 2022 bebtelovimab was the only available mAb to show preserved in vitro activity against the omicron BA.4 and BA.5 subvariants that were superceding previous omicron subvariants at that time [1].
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
12145 bebtelovimab
Synonyms Click here for help
LY-3853113 | LY-CoV-1404 | LY-CoV1404 | LY3853113
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1238
Other databases
GtoPdb PubChem SID 461663476
Search PubMed clinical trials bebtelovimab
Search PubMed titles bebtelovimab
Search PubMed titles/abstracts bebtelovimab